LACunar Intervention Trial-3 (LACI-3)

LACunar Intervention Trial-3 (LACI-3): Assessment of efficacy and safety of cilostazol and isosorbide mononitrate to prevent adverse outcomes in patients with cerebral small vessel disease (lacunar) ischaemic stroke.

Research

LACI-3 Researchers examining brain scan

What is Laci-3?

Trial Information

Group of researchers and nurses sitting around the table

Information for Researchers

News

Three women of varying ages example a laptop together

About us.

Patients

A nurse with dark hair speaks to an elderly man.

Who can participate?

Sites

A man in a shirt and tie shaking the hand of another man who is sitting down on a couch

Which UK hospitals are participating?

For Investigators

Blue key on a white keyboard

Trial Staff Login

Contact the Laci-3 trial team: laci-3@ed.ac.uk

LACI-3 is managed by the the Trial Coordinating Centre:

LACI-3 Trial

Centre for Clinical Brain Science

Chancellor’s Building

49 Little France Crescent

Edinburgh

EH16 4SB

This article was published on